- Donald Trump's inauguration day failed to move the FTSE 100 in either direction, but investors continued to have jitters about the President-elect's warning over drug pricing.

The main pharma fallers were AstraZeneca (AZN) and rare diseases specialist Shire (SHP), which dropped 3.4% and 1.9%, respectively.

West Texas Intermediate and Brent crude oil rallied by over 2% to $52.60 and $55.60 per barrel, respectively.

Gold rose 0.2% to $1,203 per ounce and copper climbed 0.7% to $5,776 per tonne.

On Wall Street, the market seemed relatively optimistic about Trump's upcoming presidency as the S&P 500 and Dow Jones gained 0.5%.

Japan's Nikkei 225 and Shanghai's SSE Composite were in the black, while the Hang Seng index in Hong Kong slumped by 0.7%.


Copper miner Antofagasta (ANTO) said it plans to sell its 40% stake in the Alto Maipo hydroelectric power project to partner AES Gener and exit the project entirely.


Chemicals maker Synthomer (SYNT) revealed estimated 2016 underlying pre-tax profit at constant currencies will beat market expectations. The market toasted fourth-quarter trading, which was boosted by stronger-than-expected trading in Europe and Asia.


Investors are excited about life sciences group Abzena's (ABZA) licensing agreement with a San Diageo-based biopharma firm for the use of its tech that links antibodies and other proteins to drugs. Abzena said the value of the deal has the potential to reach over $300m, sparking a 58% rally in the stock.

Sovereign Mines of Africa (SMA) completed the form-out of its 75% interest in the Mandiana gold project in West Africa to Volcanic Metals, causing the stock to rally 37.7%.

Greatland Gold (GGP) continued to rally on yesterday's announcement that it found hold mineralisation at its Ernest Giles project in Western Australia. The shares surged 38.2%.

Sleep tracker distributor Fitbug (FITB) was hit by a further 16.7% slump in its share price as investors were still frustrated that its latest contract was only worth £60,000. The market caused the stock to soar by 370% on Wednesday on the original announcement.

Translation software company SDL (SDL) was optimistic as it reported that its 2016 performance will beat expectations due to the weaker pound. The stock rallied 7.9% to 496.7p.

Character Group (CCT), the firm behind Peppa Pig, fell 6% to 488p as it warned investors to expect a weak first half. The weak pound squeezed margins, which means the company has to work harder to meet full year forecasts.

Research agency BrainJuicer (BJU) reported 2016 gross profit increased by nearly a third to £25.6m, which was driven by strong progress by its US business and further recovery in Continental Europe.

Pharmaceutical company Midatech Pharma (MTPH) gained 11% as its reported total revenue for the year to 31 December is expected to rise more than six-fold from £1.4m to £9m.

Shares in software supply firm Elecosoft (ELCO) jumped 18.4% to 35.5p as it expects 2016 profit will significantly beat market expectations before M&A costs.

Analysts anticipated a strong year as they forecast record adjusted pre-tax profit of £1.4m compared to £1.1m in 2015. FinnCap upgraded its estimate to £1.7m.

Story provided by